Ulta Beauty Shares Drop 1.09% as Armra Partnership Drives Expansion Strategy, Ranked 385th in $300M Trading Volume

Ulta Beauty (ULTA) fell 1.09% on July 29, 2025, with a trading volume of $0.30 billion, ranking 385th in the day’s stock activity. The decline followed the nationwide launch of physician-founded wellness brand Armra’s colostrum products at Ulta’s Wellness Shop, both in-store and online. Armra’s entry into Ulta’s curated wellness portfolio highlights the retailer’s focus on expanding its offerings in beauty and holistic health, aligning with growing consumer demand for science-backed ingestibles.

Analysts noted that Ulta’s stock performance lagged broader market benchmarks, closing at $513.88. The company’s recent strategic moves, including partnerships with brands like Charlotte Tilbury and VT-Cosmetics, underscore its efforts to strengthen its position in the competitive beauty retail sector. However, mixed signals emerged as Loop Capital analyst Anthony Chukumba downgraded Ulta to a Hold, citing valuation concerns despite strong operational momentum under new CEO Kecia Steelman.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day generated a 166.71% return from 2022 to the present, far outpacing the benchmark return of 29.18%. This approach delivered a 137.53% excess return, a 31.89% CAGR, and a Sharpe ratio of 1.14, demonstrating robust risk-adjusted performance with no maximum drawdown recorded.